Sort
85,873 grants matching “alzheimers”
EXCITATORY TRANSMITTERS, MEMORY, AGING AND DEMENTIA
$1,417,485Washington University · P01 · FY2000 · AG
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,417,321Charbel Moussa · Georgetown University · R01 · FY2019 · AG
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,417,321Charbel Moussa · Georgetown University · R01 · FY2020 · AG
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,417,321Charbel Moussa · Georgetown University · R01 · FY2022 · AG
AMP-AD Data Coordination Center
$1,417,076Lara M Mangravite · Sage Bionetworks · U24 · FY2020 · AG
Optimizing a closed-loop digital meditation intervention for remediating cognitive decline and reducing stress in older adults
$1,416,814David A Ziegler · University Of California, San Francisco · R01 · FY2024 · AG
Optimizing a closed-loop digital meditation intervention for remediating cognitive decline and reducing stress in older adults
$1,416,705David A Ziegler · University Of California, San Francisco · R01 · FY2023 · AG
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
$1,416,252Linda J Van Eldik · University Of Kentucky · U01 · FY2015 · AG
HEALTHY AGING AND SENILE DEMENTIA
$1,415,847John Morris · Washington University · P01 · FY2011 · AG
Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease
$1,415,787Lawrence R. Frank · University Of California, San Diego · R01 · FY2023 · AG
Person-Centered Mobile App for AD/ADRD Family Caregivers
$1,415,639Joseph Chung · Kinto · R44 · FY2019 · AG
Micronutrients, stroke and cognition in aging
$1,415,587Tufts University Boston · R01 · FY2005 · AG
Unraveling the synaptic and circuit mechanisms underlying a plasticity-driving instructive signal
$1,415,167Christine Grienberger · Brandeis University · DP2 · FY2023 · MH
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
$1,414,700Priya Palta · Columbia University Health Sciences · R01 · FY2020 · AG
Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease
$1,414,551David Loewenstein · University Of Miami School Of Medicine · R01 · FY2023 · AG
Adding technology that will enhance commercialization of our neuroscience-based innovative assistive technology platform for living with Alzheimer's disease and Alzheimer's disease related dementia
$1,414,367Matthew Golden · Maphabit, Inc. · SB1 · FY2025 · AG
Activity-dependent probes for spatially-defined proteomics
$1,414,340Christina Kim · University Of California At Davis · DP2 · FY2023 · MH
Dementia with Lewy Bodies Consortium
$1,414,297James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · NS
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers
$1,413,975Allan I Levey · Emory University · U01 · FY2021 · AG
University of Florida - Mt. Sinai Medical Center AD Research Center
$1,413,712Todd E. Golde · University Of Florida · P50 · FY2017 · AG
Technical/Data Core
$1,413,415Julie Pw Bynum · Brown University · U54 · FY2021 · AG
The LUCINDA Trial
$1,413,113Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
University of Florida - Mt. Sinai Medical Center AD Research Center
$1,412,772Todd E. Golde · University Of Florida · P50 · FY2018 · AG
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
$1,412,771Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · U01 · FY2021 · AG
FRONTOTEMPORAL DEMENTIA: GENES, IMAGES, AND EMOTIONS
$1,412,709University Of California San Francisco · P01 · FY2002 · AG